Unichem Laboratories Limited (BOM:506690)
376.60
-8.95 (-2.32%)
At close: May 5, 2026
Unichem Laboratories Market Cap
Unichem Laboratories has a market cap or net worth of 26.51 billion as of May 6, 2026. Its market cap has decreased by -33.74% in one year.
Market Cap
26.51B
Enterprise Value
29.60B
Revenue
22.14B
Ranking
n/a
PE Ratio
9.01
Stock Price
376.60
Market Cap Chart
Since July 30, 2001, Unichem Laboratories's market cap has increased from 5.81B to 26.51B, an increase of 356.58%. That is a compound annual growth rate of 6.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 26.51B | -14.67% |
| Dec 31, 2025 | 31.07B | -40.43% |
| Dec 31, 2024 | 52.16B | 82.07% |
| Dec 29, 2023 | 28.65B | 28.87% |
| Dec 30, 2022 | 22.23B | 27.19% |
| Dec 31, 2021 | 17.48B | -5.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gufic Biosciences | 29.32B |
| Bliss GVS Pharma | 29.03B |
| Novartis India | 25.23B |
| Hikal | 23.41B |
| Morepen Laboratories | 22.98B |
| Amrutanjan Health Care | 16.49B |
| Kwality Pharmaceuticals | 16.41B |
| Fredun Pharmaceuticals | 13.37B |